(Q38476398)

3 September 2017

Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction (English)

1 reference

3 September 2017

myocardial infarction

1 reference

3

1 reference

3 September 2017

Raymond G Schlienger

1

1 reference

3 September 2017

Lorenz M Fischer

series ordinal

2

1 reference

3 September 2017

Christoph R Meier

series ordinal

4

1 reference

3 September 2017

1 January 2004

1 reference

3 September 2017

1 reference

3 September 2017

27

1 reference

3 September 2017

14

1 reference

3 September 2017

1157-1165

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200427140-00006

3 September 2017

0 references

cites work

The UK General Practice Research Database

1 reference

12 December 2020

Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England

1 reference

12 December 2020

Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction

1 reference

12 December 2020

Effect of selective serotonin reuptake inhibitors on platelet activation: can they prevent acute myocardial infarction?

1 reference

12 December 2020

Use of the UK General Practice Research Database for pharmacoepidemiology

1 reference

12 December 2020

Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction

1 reference

12 December 2020

Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement

1 reference

12 December 2020

Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study

1 reference

12 December 2020

Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update

1 reference

12 December 2020

Depression and cardiovascular morbidity and mortality: cause or consequence?

1 reference

12 December 2020

Symptoms of depression, acute myocardial infarction, and total mortality in a community sample.

1 reference

12 December 2020

A database worth saving

1 reference

12 December 2020

Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors

1 reference

12 December 2020

Exaggerated platelet reactivity in major depression

1 reference

12 December 2020

Platelet reactivity in depressed patients treated with paroxetine: preliminary findings

1 reference

12 December 2020

Paroxetine decreases platelet serotonin storage and platelet function in human beings

1 reference

12 December 2020

Selective serotonin reuptake inhibitors and myocardial infarction

1 reference

12 December 2020

Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors

1 reference

12 December 2020

Acute respiratory-tract infections and risk of first-time acute myocardial infarction

1 reference

12 December 2020

Antihypertensive drugs and fatal myocardial infarction in persons with uncomplicated hypertension.

1 reference

12 December 2020

Validation of information recorded on general practitioner based computerised data resource in the United Kingdom

1 reference

12 December 2020

Increased platelet aggregability in major depression?

1 reference

12 December 2020

Validity of the General Practice Research Database

1 reference

12 December 2020

Bleeding and selective serotonin reuptake inhibitors in childhood and adolescence

1 reference

12 December 2020

Depression and 18-month prognosis after myocardial infarction.

1 reference

12 December 2020

Subhyaloid haemorrhage with fluoxetine

1 reference

12 December 2020

Antibiotics and risk of subsequent first-time acute myocardial infarction

1 reference

12 December 2020

Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria

1 reference

12 December 2020

Intracranial haemorrhage and use of selective serotonin reuptake inhibitors

1 reference

12 December 2020

Spontaneous ecchymoses due to paroxetine administration

1 reference

12 December 2020

The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment

1 reference

12 December 2020

Bleeding from selective serotonin reuptake inhibitors: a case report

1 reference

12 December 2020

The SSRI discontinuation syndrome

1 reference

12 December 2020

Depression is a risk factor for coronary artery disease in men: the precursors study.

1 reference

12 December 2020

Coronary artery disease and depression

1 reference

12 December 2020

Are platelets the link between depression and ischemic heart disease?

1 reference

12 December 2020

Depression and cardiac mortality: results from a community-based longitudinal study

1 reference

12 December 2020

The influence of selective serotonin reuptake inhibitors on human platelet serotonin

1 reference

12 December 2020

Bleeding, a side effect of fluoxetine

1 reference

12 December 2020

Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents

1 reference

12 December 2020

SSRI discontinuation syndrome. Awareness as an approach to prevention

1 reference

12 December 2020

Platelets and coronary heart disease: potential psychophysiologic mechanisms

1 reference

12 December 2020

Risk of acute first myocardial infarction and use of nicotine patches in a general population

1 reference

12 December 2020

Sertraline treatment of major depression in patients with acute MI or unstable angina

1 reference

12 December 2020

Drug interactions of clinical significance with selective serotonin reuptake inhibitors

1 reference

12 December 2020

Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction

1 reference

12 December 2020

Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up

1 reference

12 December 2020

10.2165/00002018-200427140-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

0 references

1 reference